Biotech industry leaders share cautious optimism for 2023 amid downturn and layoffs
GeekWire
DECEMBER 27, 2022
Everyone is budgeting 50% longer to raise their rounds,” said Canestaro. In Washington, Absci , Zymeworks , TwinStrand Biosciences , NanoString Technologies and Sana Biotechnology all shed employees in 2022. million square feet, said Pete Warsinske , a life science specialist at commercial real estate company CBRE.
Let's personalize your content